Prime Medicine, Inc.PRMENASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-4226.21%
↓ 173% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-1546.46%
Historical baseline
PeriodValueYoY Change
TTM-4226.21%+35.8%
2024-6581.93%-
20230.00%-
20220.00%-
20210.00%+100.0%
2020-17.06%-
20190.00%-